Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Shaik

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Micromachines|July 27, 2024
A New Silicon Mold Process for Polydimethylsiloxane MicrochannelsLung-Jieh Yang, Sameer Shaik, Neethish Kumar Unnam, et al.
Saudi Journal of Biological Sciences|March 23, 2019
<i>In-vitro</i> antimicrobial and anticancer properties of green synthesized gold nanoparticles using <i>Anacardium occidentale</i> leaves extractVeena Sunderam, Devasena Thiyagarajan, Ansel Vishal Lawrence, et al.
Gut|September 16, 2022
SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosisAnand V Kulkarni, Chandan S Metage, Baqar Ali Gora, et al.
Journal of Clinical and Experimental Hepatology|May 30, 2023
The Pattern of Alcohol Use in Alcohol-Related Cirrhosis in Indian Patients: AUDIT Indian Liver StudyMithun Sharma, Baqar A Gora, Anand Kulkarni, et al.
Internal Medicine Journal|October 28, 2024
Impact of Karnofsky performance status on outcomes of patients with severe alcohol-associated hepatitis: a propensity-matched analysisAnand V Kulkarni, Shantan Venishetty, Karan Kumar, et al.
Journal of Clinical and Experimental Hepatology|July 13, 2023
Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian ExperienceAnand V Kulkarni, Vamsi Krishna, Karan Kumar, et al.
Annals of Hepatology|April 7, 2023
Early living donor liver transplantation for alcohol-associated hepatitisAnand V Kulkarni, Raghuram Reddy, Juan Pablo Arab, et al.
Vaccine|November 14, 2022
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipientsAnand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, et al.
The American Journal of Gastroenterology|November 9, 2023
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) TrialAnand V Kulkarni, Mahathi Avadhanam, Puja Karandikar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Micromachines|July 27, 2024
A New Silicon Mold Process for Polydimethylsiloxane MicrochannelsLung-Jieh Yang, Sameer Shaik, Neethish Kumar Unnam, et al.
Saudi Journal of Biological Sciences|March 23, 2019
<i>In-vitro</i> antimicrobial and anticancer properties of green synthesized gold nanoparticles using <i>Anacardium occidentale</i> leaves extractVeena Sunderam, Devasena Thiyagarajan, Ansel Vishal Lawrence, et al.
Gut|September 16, 2022
SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosisAnand V Kulkarni, Chandan S Metage, Baqar Ali Gora, et al.
Journal of Clinical and Experimental Hepatology|May 30, 2023
The Pattern of Alcohol Use in Alcohol-Related Cirrhosis in Indian Patients: AUDIT Indian Liver StudyMithun Sharma, Baqar A Gora, Anand Kulkarni, et al.
Internal Medicine Journal|October 28, 2024
Impact of Karnofsky performance status on outcomes of patients with severe alcohol-associated hepatitis: a propensity-matched analysisAnand V Kulkarni, Shantan Venishetty, Karan Kumar, et al.
Journal of Clinical and Experimental Hepatology|July 13, 2023
Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian ExperienceAnand V Kulkarni, Vamsi Krishna, Karan Kumar, et al.
Annals of Hepatology|April 7, 2023
Early living donor liver transplantation for alcohol-associated hepatitisAnand V Kulkarni, Raghuram Reddy, Juan Pablo Arab, et al.
Vaccine|November 14, 2022
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipientsAnand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, et al.
The American Journal of Gastroenterology|November 9, 2023
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) TrialAnand V Kulkarni, Mahathi Avadhanam, Puja Karandikar, et al.
Pageof 1